Cellectis S.A. (CLLS)

NASDAQ: CLLS · Real-Time Price · USD

3.900

-0.090 (-2.26%)

Feb 20, 2026, 4:00 PM EST - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Therapeutics	49.22M	9.19M	25.72M	38.60M	59.56M
Therapeutics Growth	435.37%	-64.26%	-33.35%	-35.20%	279.49%
Total	49.22M	9.19M	25.72M	38.60M	59.56M
Total Growth	435.37%	-64.26%	-33.35%	-35.20%	159.09%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
France	41.51M	755.00K	19.17M	30.35M	51.06M
France Growth	5397.35%	-96.06%	-36.83%	-40.56%	546.62%
Unallocated	7.71M	8.44M	6.55M	8.25M	8.51M
Unallocated Growth	-8.60%	28.77%	-20.57%	-3.02%	9.06%
Total	49.22M	9.19M	25.72M	38.60M	59.56M
Total Growth	435.37%	-64.26%	-33.35%	-35.20%	159.09%

Source: S&P Global Market Intelligence.